David Pariser Selected Research

Adrenal Cortex Hormones (Corticosteroids)

10/2017	Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
9/2013	A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
5/2009	Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
9/2005	Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
8/2005	A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Pariser Research Topics

Disease

22	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2023 - 11/2003
10	Atopic Dermatitis (Atopic Eczema) 01/2020 - 10/2004
6	Acne Vulgaris 03/2015 - 11/2004
4	Infections 01/2020 - 01/2008
4	Erythema 08/2018 - 10/2004
3	Hyperhidrosis 05/2022 - 04/2018
3	Body Weight (Weight, Body) 01/2020 - 11/2003
3	Actinic Keratosis 01/2019 - 01/2007
2	Eczema 01/2020 - 10/2017
2	Conjunctivitis 01/2020 - 10/2017
2	Injection Site Reaction 01/2020 - 10/2017
2	Pruritus (Itching) 03/2017 - 10/2004
2	Skin Neoplasms (Skin Cancer) 07/2015 - 01/2007
1	Hidradenitis Suppurativa 03/2024
1	Benign Familial Pemphigus (Hailey Hailey Disease) 04/2023
1	Skin Diseases (Skin Disease) 06/2022
1	Long Term Adverse Effects 01/2022
1	Diarrhea 01/2022
1	Headache (Headaches) 01/2022
1	Mycosis Fungoides 01/2022
1	Nasopharyngitis 01/2022
1	Nausea 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022
1	Chronic Disease (Chronic Diseases) 08/2018
1	Asthma (Bronchial Asthma) 10/2017
1	Neoplasms (Cancer) 07/2015
1	Virus Diseases (Viral Diseases) 05/2015
1	Onychomycosis (Tinea Unguium) 06/2013
1	Hemolytic Anemia 12/2008
1	Glucosephosphate Dehydrogenase Deficiency 12/2008
1	Hemolysis 12/2008
1	Rosacea (Acne Rosacea) 10/2007

Drug/Important Bio-Agent (IBA)

7	Etanercept (Enbrel)FDA Link 01/2015 - 01/2008
5	CytokinesIBA 10/2017 - 11/2004
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2017 - 08/2005
5	pimecrolimus (Elidel)FDA Link 10/2005 - 10/2004
4	Immunoglobulin A (IgA)IBA 01/2020 - 03/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 01/2007
2	secukinumabIBA 03/2024 - 03/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 03/2015
2	SteroidsIBA 04/2023 - 08/2005
2	dupilumabIBA 01/2020 - 10/2017
2	tazarotene (Tazorac)FDA Link 08/2018 - 06/2008
2	halobetasol (ulobetasol)FDA LinkGeneric 08/2018 - 03/2017
2	AerosolsIBA 08/2016 - 12/2015
2	calcipotriene (calcipotriol)FDA LinkGeneric 08/2016 - 12/2015
2	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 08/2016 - 12/2015
2	Ustekinumab (CNTO 1275)FDA Link 07/2015 - 01/2015
2	Clobetasol (Clobetasol Propionate)FDA LinkGeneric 09/2013 - 05/2005
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2010 - 08/2007
2	Calcineurin InhibitorsIBA 05/2009 - 10/2005
2	Ointments (Pastes)IBA 10/2005 - 10/2004
2	Tacrolimus (Prograf)FDA LinkGeneric 10/2005 - 10/2004
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	Type A Botulinum Toxins (Botox)FDA Link 04/2023
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 05/2022
1	hypericinIBA 01/2022
1	apremilastIBA 01/2022
1	BromidesIBA 06/2020
1	Cholinergic Antagonists (Anticholinergics)IBA 06/2020
1	Aminolevulinic Acid (Levulan)FDA Link 01/2019
1	AntiperspirantsIBA 04/2018
1	Interleukin-4 (Interleukin 4)IBA 10/2017
1	Interleukin-13IBA 10/2017
1	Prostaglandins AIBA 01/2016
1	Infliximab (Remicade)FDA Link 07/2015
1	omega-Chloroacetophenone (Mace)IBA 07/2015
1	tofacitinibIBA 05/2015
1	Janus Kinase InhibitorsIBA 05/2015
1	Proteinase-Activated ReceptorsIBA 03/2015
1	ChemokinesIBA 03/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2015
1	Fluconazole (Zonal)FDA LinkGeneric 06/2013
1	Ciclopirox (Loprox)FDA LinkGeneric 06/2013
1	Itraconazole (Sporanox)FDA LinkGeneric 06/2013
1	Antifungal AgentsIBA 06/2013
1	Terbinafine (Lamisil)FDA LinkGeneric 06/2013
1	efinaconazoleIBA 06/2013
1	Benzoyl Peroxide FDA LinkGeneric 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010
1	Dapsone FDA Link 12/2008
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2008
1	Adapalene (Differin)FDA LinkGeneric 06/2008
1	RetinoidsIBA 06/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2008

Therapy/Procedure

16	Therapeutics 01/2022 - 11/2003
4	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2007
2	Precision Medicine 06/2023 - 06/2022
2	Biological Therapy 10/2021 - 07/2015
2	Microspheres (Microsphere) 07/2010 - 08/2007
1	Operative Surgical Procedures 04/2023
1	Drug Therapy (Chemotherapy) 06/2022
1	Occlusive Dressings (Occlusive Dressing) 01/2019
1	Injections 04/2018
1	Lipectomy (Liposuction) 04/2018
1	Lasers (Laser) 06/2013
1	Retreatment 11/2010
1	Aftercare (After-Treatment) 12/2008
1	Subcutaneous Injections 01/2008